Quick Reference to Key Papers

2025-09-17

Acute Pancreatitis

Acute Pancreatitis Assessment and Management in the First 24 Hours: Acute Pancreatitis First 24 hours.  Lee, P., Bishu, S., Breze, C., Chak, A., Gardner, T., Guda, N., Kaul, V., Muniraj, T., Papachristou, G., Schrope, B., Spagnolo, D., Strand, D., Tarnasky, P., Taylor, J. R., Wilcox, C. M., & Whitcomb, D. (2024). SMART Medical Review: SMART-MD Journal of Precision Medicine, 1(2), e19 - e48. https://doi.org/10.69734/7dcnna53

 

Autoimmune Pancreatitis

Autoimmune Pancreatitis: Approach to Diagnosis and Treatment.  Hernandez-Barco, Y. G., & Perugino, C. A. . (2024). SMART-MD Journal of Precision Medicine, 1(3), e60-e65. https://doi.org/10.69734/a5w3rj94

 

Chronic Pancreatitis

Diagnosis of Chronic Pancreatitis. Whitcomb , D.C, & Yadav, D (2024). SMART-MD Journal of Precision Medicine, 1(1), 4-13. https://doi.org/10.69734/f83fbc79

Medical Management of Pancreatitis Pain  Singh MD MSc, V. K. (2024). SMART APPROACH. SMART-MD Journal of Precision Medicine, 1(1), 1-3. https://doi.org/10.69734/2xkjd233

Pancreatic Enzyme Replacement Therapy: Background, Indications, and Pitfalls. Lieb II, John. (2025). SMART-MD Journal of Precision Medicine, 2(1), e85-e92. https://doi.org/10.69734/gqsbgc07 

Rational Use of Fecal Elastase–1 Testing for Exocrine Pancreatic Insufficiency (EPI).  Wilcox, C. M. (2024). SMART-MD Journal of Precision Medicine, 1(2), e15 - e17. https://doi.org/10.69734/hdhe8467

 Six Types of Pancreatitis Risk Factors in the Trypsinogen Gene Loci (PRSS1-PRSS2-TRB): Genetics of the PRSS1-PRSS2-TRB locus.   Geisz, A., Waqar, M., & Whitcomb, D. . (2024). SMART-MD Journal of Precision Medicine, 1(2), e1-e8. https://doi.org/10.69734/x2yz2m74

SPINK1 Genetic Variants in Pancreatitis. Waqar, M., Whitcomb, D., & Rebours, V. (2025). SMART-MD Journal of Precision Medicine, 2(1), e93 - e101. https://doi.org/10.69734/tbx0n188

 

Diabetes Mellitus

Imaging Findings of Pancreatic Changes in Type 1 Diabetes. Haberl MD, E. S., & Virostko, Ph.D., MSCI , J. (2025). SMART-MD Journal of Precision Medicine, 2(2), e105 - e109.  https://doi.org/10.69734/wfpe8y95

Immunology and clinical approach to adult-onset type 1 diabetes. Anna Casu MD, Ananya Bhatheja BA, & Tina K. Thethi MD. (2025). SMART-MD Journal of Precision Medicine, 2(2), e111 - e118.  https://doi.org/10.69734/71yw1j63

Precision Diagnostics for Monogenic Diabetes in Children. Ortega MD, H. I., & Gloyn, DPhil, A. L. . (2025). SMART-MD Journal of Precision Medicine, 2(2), e119 - e128. https://doi.org/10.69734/1e8v6h36

Cystic Fibrosis-Related Diabetes. Runchey, S., Chan, C. L., Runchey, MD, S. ., & Aljabrain MBBS, F. . (2025). SMART-MD Journal of Precision Medicine, 2(2), e129 - e138. https://doi.org/10.69734/zz6nxh21

Current State of Automated Insulin Delivery Options For Diabetes Management: A Primer For The Clinician. Tabatabai MD, I., & Forlenza, G. (2025).. SMART-MD Journal of Precision Medicine, 2(2), e139 - e148. https://doi.org/10.69734/92xeed68

Teplizumab-mzwv: Perspective on clinical practice and use at a single institution. Felton, J. L., Tuttle, A., & Sims, E. K. (2025). SMART-MD Journal of Precision Medicine, 2(2), e149 - e157. https://doi.org/10.69734/59hkbn82

 

Pancreatic Cancer (see also Pharmcogenetics [PGx]) 

CA 19-9 and pancreatic ductal adenocarcinoma (PDAC)   Whitcomb, D., Oranburg , T. D., Vallente, R., & Brand, R. E. (2024). SMART Medical Review:.: CA 19-9 and Pancreatic Cancer. SMART-MD Journal of Precision Medicine, 1(1), 14-27. https://doi.org/10.69734/psc3br75

Identifying Complex High-Risk Individuals (HRI-C) for Early Detection of Occult Pancreatic Cancers Using Risk Models and Biomarkers.   Brand, R., Whitcomb, D., & Wu, B. (2024). SMART-MD Journal of Precision Medicine, 1(3), e66-e78. https://doi.org/10.69734/525x3s54

Pancreatic Cancer Surveillance in Clinical Practice. Paul, N., & Brand, R. (2025). SMART-MD Journal of Precision Medicine, 2(1), e79-e83. https://doi.org/10.69734/rz628c44

 

Pharmacogenetics  (PGx)

Pharmacogenetic Considerations in Beta-Blocker Therapy. Yang, B., & Luzum, J. (2024). SMART-MD Journal of Precision Medicine, 1(2), e9 - e13. https://doi.org/10.69734/hpaezm84

Pharmacogenetic Considerations for Irinotecan Therapy. Pasternak, A., & Nazzal, M. (2024). SMART-MD Journal of Precision Medicine, 1(3), e49-e54. https://doi.org/10.69734/1syww840

DPYD Genotype-guided Dose Optimization of 5-Fluorouracil in Individuals with Pancreatic Cancer.   Javier Granados II, Vaibhav Sahai, & Daniel L Hertz. (2024). SMART-MD Journal of Precision Medicine, 1(3), e55-e59. https://doi.org/10.69734/ca9xy367